Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Point Of Care Lipid Test Market CAGR Outlook And Future Development#_x000D_
The point of care lipid test market has demonstrated strong growth in recent years. This market is projected to expand from $0.74 billion in 2025 to $0.82 billion in 2026, at a compound annual growth rate (CAGR) of 9.7%. The growth observed in the past can be attributed to the increasing prevalence of cardiovascular diseases, the demand for rapid testing, progress in biosensor technology, increased awareness of cholesterol management, and the availability of point-of-care devices._x000D_
_x000D_
The point of care lipid test market size is forecasted to undergo significant expansion in the coming years, with expectations to reach $1.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.4%. This anticipated growth is primarily driven by the integration of mobile applications and cloud platforms, the expansion into home care settings, increased adoption within clinics and hospitals, the development of multi-analyte tests, and collaborative efforts between device and software providers. Prominent trends throughout the forecast period include the rise of fingerstick lipid testing, the availability of portable lipid analyzers, the use of multi-parameter analyzers, rapid cardiovascular risk assessment capabilities, and the prevalence of home-based lipid monitoring solutions._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Point Of Care Lipid Test Market Expansion Drivers: What’s Shaping Future Growth?#_x000D_
The rising incidence of cardiovascular conditions is projected to boost the expansion of the point of care lipid test market in the future. Cardiovascular diseases encompass various heart and blood vessel disorders, such as coronary artery disease, stroke, and high blood pressure, frequently caused by atherosclerosis connected to irregular cholesterol and triglyceride levels. The escalating occurrence of cardiovascular ailments stems from increasingly sedentary habits and diminished physical activity, contributing to issues like obesity, poor circulation, and other risk factors for CVDs. Point-of-care lipid tests facilitate the handling of the increasing prevalence of cardiovascular diseases by offering rapid, on-site measurements of cholesterol and other lipid levels, allowing for early detection of risk and swift treatment choices to hinder disease advancement. For example, in January 2024, the American Heart Association, a US-based nonprofit organization, reported that cardiovascular disease-related deaths in the cardiovascular sector reached 931,578, an increase of 3,000 fatalities from the prior year’s total of 928,741. Consequently, the growing prevalence of cardiovascular diseases is anticipated to drive the point of care lipid test market’s growth._x000D_
_x000D_
#Point Of Care Lipid Test Market Segmentation And Category Overview#_x000D_
The point of care lipid test market covered in this report is segmented – _x000D_
_x000D_
1) By Product Types: Instruments, Consumables_x000D_
2) By Application: Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Familial Hypercholesterolemia, Other Applications_x000D_
3) By End-User: Hospitals, Clinics, Home Care Settings, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Instruments: Portable Or Handheld Analyzers, Multi-parameter Analyzers, Single-parameter Analyzers_x000D_
2) By Consumables: Test Strip, Reagents And Kits_x000D_
_x000D_
#Point Of Care Lipid Test Market Strategic Trends: What Defines The Next Growth Phase?#_x000D_
Key companies operating in the point-of-care lipid test market are concentrating on innovative solutions, such as advanced point-of-care (POC) diagnostic platforms, to provide rapid, accurate, and lab-quality lipid panel results directly at the patient’s bedside, thereby enhancing clinical decision-making and patient management. An advanced point-of-care (POC) diagnostic platform is defined as a portable, integrated device that executes quick, precise, and lab-quality tests close to the patient, facilitating real-time clinical decisions and immediate health management. For example, in July 2023, Vital Biosciences Inc., a health technology company based in Canada, launched VitalOne, a point-of-care lab testing platform engineered to deliver over 50 lab-grade blood test results in just 20 minutes utilizing a compact, automated device at locations such as clinics and pharmacies. This system unifies hematology, clinical chemistry, and immunoassays within a single instrument, allowing healthcare providers to complete testing, diagnosis, and treatment in one visit, significantly improving access, speed, and personalization of patient care, all with accuracy comparable to traditional central labs._x000D_
_x000D_
#Point Of Care Lipid Test Market Industry Leaders And Competitive Landscape#_x000D_
Major companies operating in the point of care lipid test market are Abbott Laboratories, EKF Diagnostics Holdings plc, Roche Diagnostics International AG, Siemens Healthineers AG, Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, EKF Diagnostics USA Inc., VivaChek Biotech (Hangzhou) Co. Ltd., Menarini Diagnostics S.r.l., Trinity Biotech plc, AccuBioTech Co. Ltd., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited, SD Biosensor Inc., ARKRAY Inc., PTS Diagnostics, HemoCue AB, MedTest Dx Inc., Nova Biomedical Corporation _x000D_
_x000D_
#View The Full Point Of Care Lipid Test Market Report:#_x000D_
_x000D_
#Point Of Care Lipid Test Market Regional Analysis And Top Geography#_x000D_
North America was the largest region in the point of care lipid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care lipid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.